- Trials with a EudraCT protocol (17)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
17 result(s) found for: Calcium alginate.
Displaying page 1 of 1.
| EudraCT Number: 2014-005261-69 | Sponsor Protocol Number: GA1402 | Start Date*: 2015-08-06 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
| Full Title: A multi-centre, randomised, double-blind, two arm, parallel group, placebo-controlled study to assess the effect of Sodium Alginate Chewable Tablets on symptoms of gastro-oesophageal reflux disease. | ||
| Medical condition: Gastro-Oesophageal Reflux Disease (GORD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) DE (Completed) IT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003174-17 | Sponsor Protocol Number: GA1405 | Start Date*: 2015-03-24 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
| Full Title: A multicentre, randomised, double-blind, two arm, parallel group, placebo controlled pivotal study to assess the effect of a sodium alginate liquid suspension as add-on therapy in GORD patients wit... | ||
| Medical condition: Gastro-Oesophageal Reflux Disease (GORD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-006413-25 | Sponsor Protocol Number: GA0821 | Start Date*: 2008-12-09 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
| Full Title: A single-centre randomised, partially blind, single dose, crossover study investigating the onset of action of soothing and cooling after taking Gaviscon Peppermint liquid, Double Action Gaviscon ... | ||
| Medical condition: Symptoms of heartburn | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2007-005821-31 | Sponsor Protocol Number: GA0706 | Start Date*: 2008-01-15 |
| Sponsor Name:Reckitt Benckiser Healthcare UK) Limited [...] | ||
| Full Title: A single-centre randomised, partially blind, single dose, crossover pilot study investigating the use of stopwatches to assess the onset of action of soothing and cooling of Gaviscon Peppermint Liq... | ||
| Medical condition: Symptoms of heartburn | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-003158-15 | Sponsor Protocol Number: GA1406 | Start Date*: 2014-10-10 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
| Full Title: A randomised, assessor blind, placebo controlled exploratory study in healthy volunteers, to characterise the acid neutralisation activity of sodium alginate oral suspension in the fasted state, us... | ||
| Medical condition: To pilot the use of a custom designed pH catheter for the measurement of intragastric pH to characterise the antacid action of Gaviscon Double Action versus placebo. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-000678-44 | Sponsor Protocol Number: GA1116 | Start Date*: 2012-09-04 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A single-centre, randomised, four-way crossover study to investigate the measurement of the acid pocket and subsequent gastro-oesophageal reflux episodes using a novel pH/impedance catheter in subj... | ||
| Medical condition: A single-centre, randomised, four-way crossover study to investigate the measurement of the acid pocket and subsequent gastro-oesophageal reflux episodes using a novel pH/impedance catheter in subj... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2016-000539-42 | Sponsor Protocol Number: RB2-NL-1518 | Start Date*: 2016-04-15 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Limited | ||
| Full Title: A randomised, single dose, crossover, open label, placebo controlled confirmatory study in healthy volunteers to characterise the acid neutralisation activity of Gaviscon Double Action Liquid in th... | ||
| Medical condition: To investigate the pH of the acid in the stomach of healthy volunteers after the intakeof Gaviscon Double Action liquid. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-002341-35 | Sponsor Protocol Number: GA1103 | Start Date*: 2011-07-21 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A randomised single dose two cohort study comparing the speed of raft formation assessed by gamma scintigraphy in healthy volunteers following administration of a single dose of Gaviscon® Strawberr... | ||
| Medical condition: To measure the formation and retention of alginate rafts in healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-021630-63 | Sponsor Protocol Number: GA1001 | Start Date*: 2011-03-28 |
| Sponsor Name:Reckitt Benckiser | ||
| Full Title: A randomised, double blind placebo controlled study in patients with reflux symptoms to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Peppermint liquid’ using the BRAVO... | ||
| Medical condition: Gastro-oesophageal reflux disease (GORD) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-019414-24 | Sponsor Protocol Number: GA0921 | Start Date*: 2010-07-09 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A single centre, randomised, partially-blind, placebo-controlled 3 way crossover pilot study investigating efficacy in terms of heartburn relief after taking (2x250mg) Gaviscon® chewable tablets... | ||
| Medical condition: Investigating efficacy in terms of heatburn relief in healthy subjects following a refluxogenic meal. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2011-004725-27 | Sponsor Protocol Number: GA1109 | Start Date*: 2012-01-24 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A single-centre, randomised, double-blind, two-way crossover, placebo-controlled pilot study, investigating the use of a novel intragastric and oesophageal pH catheter to characterise the antacid a... | ||
| Medical condition: To pilot the use of a novel pH catheter for the measurement of oesophageal and intragastric pH comparing the onset and duration of antacid action of Gaviscon Double Action versus placebo. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004109-28 | Sponsor Protocol Number: GA1211 | Start Date*: 2013-01-18 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A randomised, 4 way crossover, double blind, placebo controlled pilot study in patients with reflux symptoms, to assess suppression of gastro-oesophageal reflux by ‘Gaviscon Double Action Mint ’ us... | ||
| Medical condition: This study assesses suppression of gastro-oesophageal reflux of Gaviscon in patients with gastro-oesophageal reflux disease. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-002188-84 | Sponsor Protocol Number: GA1203 | Start Date*: 2012-07-27 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) LTD | ||
| Full Title: A multi-centred, randomised, double-blind, two arm, parallel group, placebo-controlled, pilot study to assess the effect of Gaviscon Double Action Tablets in patients with reflux disease | ||
| Medical condition: This pilot study of Gaviscon Double Action Tablets is to be conducted to demonstrate that Gaviscon Double Action Tablets are effective in managing the symptoms of heartburn, acid regurgitation and ... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004131-23 | Sponsor Protocol Number: GA1212 | Start Date*: 2013-01-18 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A single-centre, randomised, 2 way crossover, double blind, placebo controlled study in healthy volunteers, to characterise the antacid activity of Gaviscon Double Action Mint Liquid in the fasted ... | ||
| Medical condition: This study is to demonstrate the antacid action of Gaviscon Double Action Mint versus a matched placebo using a pH catheter. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2012-004470-25 | Sponsor Protocol Number: GA1214 | Start Date*: 2013-01-08 |
| Sponsor Name:Reckitt Benckiser Healthcare (UK) Ltd | ||
| Full Title: A multicentre, randomised, double-blind, two arm, parallel group, pilot study to assess the effect of Gaviscon® Double Action Mint as add-on therapy in GORD patients with inadequate response to onc... | ||
| Medical condition: Patients with Gastro Oesophageal Reflux Disease (GORD) with inadequate response to PPI treatment | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2010-022082-10 | Sponsor Protocol Number: ZEG/01-2010 (GERD) | Start Date*: 2011-02-09 |
| Sponsor Name:Norgine Ltd | ||
| Full Title: A double-blind, double-dummy, randomised, study to assess the superiority of Zegerid® 20 mg vs. Losec® 20 mg in the rapid relief of heartburn associated with GERD as on demand therapy. | ||
| Medical condition: Heartburn associated with gastro-oesophageal reflux disease (GERD) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) CZ (Completed) HU (Completed) BG (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2020-005263-31 | Sponsor Protocol Number: LEVOKETO_02-2020 | Start Date*: 2021-06-02 | |||||||||||
| Sponsor Name:NTC SRL | |||||||||||||
| Full Title: Assessment of the effects and tolerability of RD03/2016 (Levofloxacin; Ketorolac Trometamol 0.5+0.5% w/v eye drops solution) for the treatment of bacterial conjunctivitis in adults: a multicentre, ... | |||||||||||||
| Medical condition: Bacterial conjunctivitis | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) IT (Completed) DE (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
